title: High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.
authors.affiliation: Department of Internal Medicine, Seoul National University Hospital, 101 Daehang-Ro, Jongno-Gu, Seoul, Korea.
authors.forename: Jiyoung
authors.initials: J
authors.lastname: Rhee
authors.forename: Sae-Won
authors.initials: SW
authors.lastname: Han
authors.forename: Yongjun
authors.initials: Y
authors.lastname: Cha
authors.forename: Hye Seon
authors.initials: HS
authors.lastname: Ham
authors.forename: Hwang-phill
authors.initials: HP
authors.lastname: Kim
authors.forename: Do-Youn
authors.initials: DY
authors.lastname: Oh
authors.forename: Seock-Ah
authors.initials: SA
authors.lastname: Im
authors.forename: Jong-Wan
authors.initials: JW
authors.lastname: Park
authors.forename: Jungsil
authors.initials: J
authors.lastname: Ro
authors.forename: Keun Seok
authors.initials: KS
authors.lastname: Lee
authors.forename: In Hae
authors.initials: IH
authors.lastname: Park
authors.forename: Young-Hyuck
authors.initials: YH
authors.lastname: Im
authors.forename: Yung-Jue
authors.initials: YJ
authors.lastname: Bang
authors.forename: Tae-You
authors.initials: TY
authors.lastname: Kim